Literature DB >> 16439767

Nutrition aspects of gastroparesis and therapies for drug-refractory patients.

Thomas L Abell1, Scott Malinowski, Anil Minocha.   

Abstract

Gastroparesis, broadly defined as disordered gastric emptying, is a commonly encountered clinical problem. Nutrition problems frequently occur in gastroparesis, primarily due to inadequate oral intake but also due to losses from vomiting or diarrhea. Treatment of gastroparesis may include dietary modification with or without medication. Some patients require supplementation with either enteral or parenteral nutrition for survival. However, many patients with gastroparesis are drug-refractory and invariably do not do well with enteral or parenteral access. Historically, these patients have been without effective therapeutic options. The development of gastrointestinal electrical stimulation has allowed many with drug-refractory gastroparesis to be treated successfully. Enteric electrical stimulation for gastroparesis often corrects many of the nutrition abnormalities, along with improving symptoms and quality of life and reducing costs; for some categories of patients, it may improve survival rates.

Entities:  

Mesh:

Year:  2006        PMID: 16439767     DOI: 10.1177/011542650602100123

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  10 in total

1.  Pacing the gut in motility disorders.

Authors:  Jing Zhang; J D Z Chen
Journal:  Curr Treat Options Gastroenterol       Date:  2006-07

Review 2.  Treatment of refractory diabetic gastroparesis: Western medicine and traditional Chinese medicine therapies.

Authors:  Bing Pang; Qiang Zhou; Jun-Ling Li; Lin-Hua Zhao; Xiao-Lin Tong
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

Review 3.  Interstitial cells of Cajal, the Maestro in health and disease.

Authors:  Randa-M Mostafa; Yasser M Moustafa; Hosam Hamdy
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

4.  Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesis.

Authors:  Henry P Parkman; Katherine P Yates; William L Hasler; Linda Nguyan; Pankaj J Pasricha; William J Snape; Gianrico Farrugia; Jorge Calles; Kenneth L Koch; Thomas L Abell; Richard W McCallum; Dorothy Petito; Carol Rees Parrish; Frank Duffy; Linda Lee; Aynur Unalp-Arida; James Tonascia; Frank Hamilton
Journal:  Gastroenterology       Date:  2011-04-28       Impact factor: 22.682

5.  Management of Gastroparesis.

Authors:  Ting Zheng; Michael Camilleri
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-11

Review 6.  Diabetic gastroparesis: diagnosis and management.

Authors:  Jing Ma; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

7.  Postprandial plasma glucose response and gastrointestinal symptom severity in patients with diabetic gastroparesis.

Authors:  Eva A Olausson; Håkan Grundin; Mats Isaksson; Christina Brock; Asbjørn M Drewes; Stig Attvall; Magnus Simrén
Journal:  J Diabetes Sci Technol       Date:  2014-05-06

8.  Diabetic gastroparesis: Therapeutic options.

Authors:  Uazman Alam; Omar Asghar; Rayaz Ahmed Malik
Journal:  Diabetes Ther       Date:  2010-10-26       Impact factor: 2.945

Review 9.  Gastroparesis in children.

Authors:  Efstratios Saliakellis; Maria Fotoulaki
Journal:  Ann Gastroenterol       Date:  2013

10.  Loss of HCN2 leads to delayed gastrointestinal motility and reduced energy intake in mice.

Authors:  Daniel W Fisher; Phillip Luu; Neha Agarwal; Jonathan E Kurz; Dane M Chetkovich
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.